Open AccessResponse by Mann et al to Letter Regarding Article, “Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial”
Author(s) -
Johannes F.E. Mann,
Vivian Fonseca,
Ofri Mosenzon,
Itamar Raz,
Bryan Goldman,
Thomas Idorn,
Bernt Johan von Scholten,
Neil R Poulter
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.040419
Subject(s) - medicine , liraglutide , placebo , kidney disease , diabetes mellitus , type 2 diabetes mellitus , disease , type 2 diabetes , alternative medicine , endocrinology , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom